WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2024

Aug 8, 2024

SEC Form 4/A — Form 4/A

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2024-05-07

Reporting Person: Green Eric Mark (Director, President, CEO and Board Chair)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-07	Common Stock	M	9316	$57.38	Acquired	162224.1245	Direct
2024-05-07	Common Stock	M	15684	$57.38	Acquired	177908.1245	Direct
2024-05-07	Common Stock	M	41000	$59.64	Acquired	218908.1245	Direct
2024-05-07	Common Stock	S	9316	$366.6419	Disposed	209952.1245	Direct
2024-05-07	Common Stock	S	15684	$366.6589	Disposed	193908.1245	Direct
2024-05-07	Common Stock	S	41000	$366.6521	Disposed	152908.1245	Direct
2024-05-07	Common Stock	M	9000	$59.64	Acquired	161908.1245	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-05-07	Stock Option (Right to Buy)	$57.38	M	9316	Disposed	2025-04-24	Common Stock (9316)	Direct
2024-05-07	Stock Option (Right to Buy)	$57.38	M	15684	Disposed	2025-04-24	Common Stock (15684)	Direct
2024-05-07	Stock Option (Right to Buy)	$59.64	M	41000	Disposed	2026-02-23	Common Stock (41000)	Direct
2024-05-07	Stock Option (Right to Buy)	$59.64	M	9000	Disposed	2026-02-23	Common Stock (9000)	Direct

Footnotes

F1: The shares reported were acquired by the Reporting Person from exercising a portion of a stock option award expiring in either 2025 or 2026, pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was completed pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on 11/17/2023.

F2: The price reported in Column 4 is a weighted average price.